Stockreport

IceCure Expected to Report Record Fourth Quarter Sales in North America Driven by Recent FDA Clearance of ProSense® Cryoablation for Low-Risk Breast Cancer

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF ProSense® systems are being sold and installed at new locations across North America, including some of the most highly regarded medical institutions in the United State [Read more]